Provoking Factors for Deep Vein Thrombosis

Classification Framework

The presence and type of provoking factor is the single most important variable influencing recurrent VTE risk after stopping anticoagulation, according to the Journal of Thrombosis and Haemostasis 4

Surgery with general anesthesia >30 minutes confers >10-fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 3 months before the DVT 5, 2
Hospital bed confinement ≥3 days with acute illness confers >10-fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 3 months before the DVT 5, 2
Cesarean section confers >10-fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 3 months before the DVT 5, 2

Surgery with general anesthesia <30 minutes confers 3-10 fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 2 months before the DVT 5, 2
Hospital admission <3 days with acute illness confers 3-10 fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 2 months before the DVT 5, 2
Estrogen therapy, such as oral contraceptives or hormone replacement therapy, confers 3-10 fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 2 months before the DVT 5, 2
Pregnancy or puerperium confers 3-10 fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 2 months before the DVT 5, 2
Confined to bed outside hospital ≥3 days with acute illness confers 3-10 fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 2 months before the DVT 5, 2
Leg injury with reduced mobility ≥3 days confers 3-10 fold increased risk of first DVT and reduces recurrence risk by half when it occurred within 2 months before the DVT 5, 2

Active cancer is the most important persistent provoking factor due to high incidence and strong association with recurrent thrombosis, according to the Journal of Thrombosis and Haemostasis 1, 3, 4
Inflammatory bowel disease is associated with ≥2-fold increased risk of recurrent VTE, according to the Journal of Thrombosis and Haemostasis 5, 2, 4
Chronic inflammatory conditions, including autoimmune diseases and chronic infections, confer the highest recurrence risk, according to the Journal of Thrombosis and Haemostasis 1, 3, 4

Recent surgery is a risk factor for VTE in long-distance travelers, according to Blood advances 6
History of VTE is a risk factor for VTE in long-distance travelers, according to Blood advances 6
Postpartum status is a risk factor for VTE in long-distance travelers, according to Blood advances 6
Active malignancy is a risk factor for VTE in long-distance travelers, according to Blood advances 6
≥2 risk factors combined, including hormone replacement therapy, obesity, or pregnancy, is a risk factor for VTE in long-distance travelers, according to Blood advances 6

Intrinsic factors, such as hereditary thrombophilias, male sex, and older age, do not influence whether VTE is considered provoked or unprovoked, though they may affect individual recurrence risk stratification, according to the Journal of Thrombosis and Haemostasis 5, 2, 7, 4
Mixed presentations require careful assessment, as patients may have both transient and persistent factors simultaneously, placing them at intermediate recurrence risk between the two categories, according to the Journal of Thrombosis and Haemostasis 1, 3, 5
Comorbidities matter only if they increase VTE risk, such as rheumatoid arthritis, which only influences classification if it is sufficiently associated with recurrent VTE (≥2-fold increased risk), according to the Journal of Thrombosis and Haemostasis 1, 3, 5